Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL21854853

CCNC(=O)[C@@H]1CNCCN1C(=O)OCc1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.47
PRCP P42785 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.45
TSHR P16473 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KMT2A Q03164 1/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
PDK1 Q15118 1/20 0.45
PDK2 Q15119 1/20 0.45
PDK3 Q15120 1/20 0.45
PDK4 Q16654 1/20 0.45
CTRB1 P17538 1/20 0.44
F2 P00734 2/20 0.44
F9 P00740 1/20 0.44
F10 P00742 1/20 0.44
F12 P00748 1/20 0.44
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
F7 P08709 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL21854752 0.92 F2 (0.46) HTR2CPRCPTSHRKMT2APDK1
Trifluoroacetic Acid SCHEMBL28969098 0.90 PRCP (0.61) HTR2CPRCPSMN1; SMN2TSHRL3MBTL1
Trifluoroacetic Acid SCHEMBL21854716 0.88 CTRB1 (0.52) HTR2CPRCPTSHRL3MBTL1KMT2A
Trifluoroacetic Acid SCHEMBL21854670 0.88 KDM4E (0.52) HTR2CTSHRL3MBTL1KMT2AKDM4E
Trifluoroacetic Acid SCHEMBL30253251 0.88 HTR2C (0.46) HTR2CSMN1; SMN2TSHRL3MBTL1KMT2A
SCHEMBL1257136 0.85 HTR2C (0.50) HTR2CPRCPSMN1; SMN2TSHRL3MBTL1
SCHEMBL2439870 0.84 TSHR (0.48) HTR2CPRCPSMN1; SMN2TSHRL3MBTL1
SCHEMBL2439873 0.84 TSHR (0.48) HTR2CPRCPSMN1; SMN2TSHRL3MBTL1
SCHEMBL21854732 0.84 HTR2C (0.51) HTR2CPRCPSMN1; SMN2TSHRL3MBTL1
SCHEMBL8707997 0.83 NPSR1 (0.49) HTR2CPRCPTSHRL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081917-A1 ΒETA-CATENIN AND B-CELL LYMPHOMA 9 (BCL9) INHIBITORS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2020-04-23 WO disclosed